In contrast, we show that methylstat alone had cytotoxic effects on both, PARPi-sensitive and PARPi-resistant ovarian cancer cells, while additionally potentiating the effect of olaparib among PARPi-resistant, PARPi-sensitive and BRCA1-proficient cell lines. Here, BRCA1 is linked to ovarian carcinoma.